Frédéric Pinguet

2.5k total citations
95 papers, 1.8k citations indexed

About

Frédéric Pinguet is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Frédéric Pinguet has authored 95 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 33 papers in Molecular Biology and 15 papers in Organic Chemistry. Recurrent topics in Frédéric Pinguet's work include Cancer Treatment and Pharmacology (29 papers), Cancer therapeutics and mechanisms (20 papers) and Colorectal Cancer Treatments and Studies (14 papers). Frédéric Pinguet is often cited by papers focused on Cancer Treatment and Pharmacology (29 papers), Cancer therapeutics and mechanisms (20 papers) and Colorectal Cancer Treatments and Studies (14 papers). Frédéric Pinguet collaborates with scholars based in France, Belgium and United States. Frédéric Pinguet's co-authors include Françoise Bressolle, Isabelle Solassol, Sylvain Poujol, Cécile Astre, C. Astre, Stéphane Culine, Marc Ychou, Xavier Quantin, Michel Fabbro and Carine Deleuze‐Masquéfa and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Frédéric Pinguet

94 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Pinguet France 24 636 575 273 235 146 95 1.8k
Angélo Paci France 31 850 1.3× 1.0k 1.8× 181 0.7× 467 2.0× 264 1.8× 201 3.5k
Matthijs M. Tibben Netherlands 21 832 1.3× 428 0.7× 242 0.9× 175 0.7× 149 1.0× 58 1.5k
M. J. X. Hillebrand Netherlands 31 812 1.3× 769 1.3× 108 0.4× 253 1.1× 289 2.0× 77 2.6k
Ti Li Loo United States 29 699 1.1× 920 1.6× 301 1.1× 293 1.2× 140 1.0× 103 2.4k
Barry R. Goldspiel United States 31 1.4k 2.3× 1.2k 2.1× 62 0.2× 335 1.4× 318 2.2× 66 3.1k
Alain Deroussent France 21 402 0.6× 529 0.9× 140 0.5× 132 0.6× 125 0.9× 47 1.5k
Jean‐Pierre Sommadossi United States 35 759 1.2× 1.0k 1.8× 201 0.7× 182 0.8× 302 2.1× 98 3.8k
Mirjam Crul Netherlands 18 447 0.7× 490 0.9× 73 0.3× 187 0.8× 127 0.9× 75 1.2k
J. Schellens Netherlands 20 1.2k 1.9× 594 1.0× 30 0.1× 234 1.0× 275 1.9× 37 1.8k
Mark Jones United Kingdom 22 728 1.1× 433 0.8× 429 1.6× 119 0.5× 56 0.4× 97 1.8k

Countries citing papers authored by Frédéric Pinguet

Since Specialization
Citations

This map shows the geographic impact of Frédéric Pinguet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Pinguet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Pinguet more than expected).

Fields of papers citing papers by Frédéric Pinguet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Pinguet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Pinguet. The network helps show where Frédéric Pinguet may publish in the future.

Co-authorship network of co-authors of Frédéric Pinguet

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Pinguet. A scholar is included among the top collaborators of Frédéric Pinguet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Pinguet. Frédéric Pinguet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leenhardt, Fanny, et al.. (2021). Sécurisation du parcours de soins du patient sous thérapie orale en oncologie : expérimentation autour d’un lien pharmaceutique hôpital–ville. Annales Pharmaceutiques Françaises. 79(5). 558–565. 4 indexed citations
2.
Leenhardt, Fanny, et al.. (2020). CN20 Oral targeted therapy dose adaptation in geriatric cancer patients: A real life French cohort. Annals of Oncology. 31. S1131–S1131.
3.
4.
5.
Khier, Sonia, Florence Gattacceca, Safia El Messaoudi, et al.. (2010). Metabolism and Pharmacokinetics of EAPB0203 and EAPB0503, Two Imidazoquinoxaline Compounds Previously Shown to Have Antitumoral Activity on Melanoma and T-Lymphomas. Drug Metabolism and Disposition. 38(10). 1836–1847. 12 indexed citations
6.
Khier, Sonia, Carine Deleuze‐Masquéfa, Georges Moarbess, et al.. (2009). Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma. European Journal of Pharmaceutical Sciences. 39(1-3). 23–29. 22 indexed citations
7.
Deleuze‐Masquéfa, Carine, Georges Moarbess, Sonia Khier, et al.. (2009). New imidazo[1,2-a]quinoxaline derivatives: Synthesis and in vitro activity against human melanoma. European Journal of Medicinal Chemistry. 44(9). 3406–3411. 37 indexed citations
8.
Moarbess, Georges, et al.. (2008). In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives. Bioorganic & Medicinal Chemistry. 16(13). 6601–6610. 106 indexed citations
9.
Duffour, Jacqueline, Sophie Gourgou, Françoise Desseigne, et al.. (2006). Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology. 60(3). 383–389. 16 indexed citations
10.
Pouessel, Damien, Stéphane Culine, Catherine Becht, et al.. (2004). Gemcitabine and docetaxel as front‐line chemotherapy in patients with carcinoma of an unknown primary site. Cancer. 100(6). 1257–1261. 36 indexed citations
11.
12.
Pinguet, Frédéric, et al.. (2001). REACTIVITY OF 6,7,8,9-TETRAHYDROPYRIDO[1,2-a]BENZIMIDAZOL-9-ONE : SYNTHESIS OF PYRROLOPYRIDOBENZIMIDAZOLES. Heterocyclic Communications. 7(1). 23–28. 2 indexed citations
13.
Pinguet, Frédéric, et al.. (2001). Pharmaco-economic study of intensive chemotherapy with peripheral blood progenitor cell support for advanced breast cancer. Oncology Reports. 8(5). 1013–7. 1 indexed citations
14.
Pinguet, Frédéric, et al.. (2000). High-performance liquid chromatographic determination of vinorelbine in human plasma and blood: application to a pharmacokinetic study. Journal of Chromatography B Biomedical Sciences and Applications. 748(2). 389–399. 21 indexed citations
15.
Lokiec, François, Frédéric Pinguet, Stéphane Culine, et al.. (2000). Population pharmacokinetics of topotecan: intraindividual variability in total drug. Cancer Chemotherapy and Pharmacology. 46(5). 375–381. 30 indexed citations
16.
Bressolle, Françoise, et al.. (1998). In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-β-cyclodextrin. European Journal of Cancer. 34(1). 168–174. 37 indexed citations
17.
Pinguet, Frédéric, et al.. (1998). Regioselective Synthesis of Pyrazolo[4,5-g]pyrido[1,2-a]benzimidazoles: Cytotoxic Derivatives of Pyrido[1,2-a]benzimidazolic Ring System.. Chemical and Pharmaceutical Bulletin. 46(11). 1820–1823. 7 indexed citations
18.
Culine, Stéphane, Michel Fabbro, Marc Ychou, et al.. (1997). Four-step high-dose sequential chemotherapy with hematopoietic progenitor-cell support as induction treatment for patients with solid tumors. Annals of Oncology. 8(10). 951–956. 9 indexed citations
19.
Galtier, Marc, et al.. (1995). Pharmacokinetic parameters of antipyrine in dog after hepatectomy. Biopharmaceutics & Drug Disposition. 16(8). 669–684. 6 indexed citations
20.
Pinguet, Frédéric, et al.. (1994). Effect of sodium chloride concentration and temperature on melphalan stability during storage and use.. PubMed. 51(21). 2701–4. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angélo Paci Breakdown of academic impact, for papers by Matthijs M. Tibben Breakdown of academic impact, for papers by M. J. X. Hillebrand Breakdown of academic impact, for papers by Ti Li Loo Breakdown of academic impact, for papers by Barry R. Goldspiel Breakdown of academic impact, for papers by Alain Deroussent Breakdown of academic impact, for papers by Jean‐Pierre Sommadossi Breakdown of academic impact, for papers by Mirjam Crul Breakdown of academic impact, for papers by J. Schellens Breakdown of academic impact, for papers by Mark Jones
Rankless by CCL
2026